1. DOP40 Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib. (30th January 2023) Authors: Dubinsky, M C; D'Haens, G; Dewit, O; Juillerat, P; Panaccione, R; Fujii, T; Lacerda, A P; Dubcenco, E; Anyanwu, S; Doshi, C; Mallick, M; Garrison, A; Liu, J; Loftus Jr, E V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. (21st October 2020) Authors: De Lima-Karagiannis, A; Juillerat, P; Sebastian, S; Pedersen, N; Bar-Gil Shitrit, A; van der Woude, C J Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 3 Page Start: S807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP06 Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression. (25th January 2019) Authors: Humbel, F; Juillerat, P; Scharl, M; Misselwitz, B; Schreiner, P; Macpherson, A; Rogler, G; von Känel, R; Yilmaz, B; Biedermann, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study. (27th May 2021) Authors: Vermeire, S; Danese, S; Zhou, W; Pangan, A; Greenbloom, S; D'Haens, G; Panes, J; Juillerat, P; Lindsay, J O; Loftus Jr, E V; Sandborn, W J; Reinisch, W; Sanchez Gonzalez, Y; Huang, B; Xie, W; Liu, J; Weinreich, M A; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P200 7α-Hydroxy-4-cholesten-3-one for diagnosis and management of bile acid malabsorption in IBD patients: 2-year clinical experience. (25th January 2019) Authors: Friedli, B; Prost, J-C; Brunner, F; Misselwitz, B; Wiest, R; Macpherson, A; Juillerat, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P350 Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland. (25th January 2019) Authors: Perrig, K; Rossel, J-B; Biedermann, L; Schreiner, P; Roth, R; Zeitz, J; Greuter, T; Vavricka, S; Krupka, N; Juillerat, P; Rogler, G; Misselwitz, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P393 Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis. (21st January 2022) Authors: Veyrard, P; Pellet, G; Laharie, D; Nachury, M; Juillerat, P; Altwegg, R; Nancey, S; Fumery, M; Allez, M; Tran minh, M L; Roblin, X Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P393 Long-term prediction of infliximab response using CD-62L shedding assay: Longitudinal data from 5-year study in inflammatory bowel disease. (16th January 2018) Authors: Macpherson, J; Bravo, F; Andrew, P; Slack, E; Patuto, N; Cahenzli, J; McCoy, K D; Macpherson, A J; Juillerat, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P414 Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacity. (21st January 2022) Authors: Bianchi, R; Von Känel, R; Roth, R; Schreiner, P; Rossel, J B; Barry, M P; Dora, B; Kloth, P; Juillerat, P; Greuter, T; Misselwitz, B; Schoepfer, A; Scharl, M; Rogler, G; Biedermann, L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P587 Quality of care indicators in inflammatory bowel disease: local pilot study. (25th January 2019) Authors: Sarraj, R; Bravo, F; Maude, M; Macpherson, A; Juillerat, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗